Loading...
•
Mar 31, 2022
Enfusion Q1 2022 Earnings Report
Enfusion's Q1 2022 results showed strong revenue growth and client acquisition.
Key Takeaways
Enfusion reported a 40% year-over-year increase in total revenue, reaching $34.1 million, driven by new client signings and growth from existing clients. The company added 42 new clients, including two seven-figure deals. However, the company experienced a net loss of $12.5 million, which includes $12.7 million in stock-based compensation.
Total revenue grew to $34.1 million, up 40% year-over-year.
Added 42 new clients in the first quarter, with record aggregate contract value.
ARR for March 2022 was $137.6 million, up 37% from March 2021.
Net Dollar Retention Rate excluding involuntary churn was 115.8%.
Forward Guidance
Enfusion provided revenue and Adjusted EBITDA guidance for Q2 2022 and full year 2022.
Positive Outlook
- Second Quarter 2022 total revenue is expected to be in the range of $35 million to $36 million.
- Second Quarter 2022 Adjusted EBITDA is expected to be in the range of $4 million to $4.5 million.
- Full Year 2022 total revenue is expected to be in the range of $148.1 million to $151.1 million.
- Full Year 2022 Adjusted EBITDA is expected to be in the range of $17.2 million to $19.2 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...